Isracann Biosciences Inc.
ISCNF · OTC
5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,693 | -$25,123 | -$23,919 | -$5,600 |
| Dep. & Amort. | $42 | $41 | $45 | $45 |
| Deferred Tax | $0 | $31 | -$69 | $0 |
| Stock-Based Comp. | $57 | $739 | $1,178 | $1,161 |
| Change in WC | $694 | -$63 | $113 | $72 |
| Other Non-Cash | $2,146 | $20,145 | $12,251 | $1,379 |
| Operating Cash Flow | -$1,755 | -$4,230 | -$10,400 | -$2,943 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$14 | -$509 | -$204 |
| Net Acquisitions | $39 | $285 | $34 | -$30 |
| Inv. Purchases | $0 | $0 | -$1,657 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$117 | -$138 | -$501 | -$623 |
| Investing Cash Flow | -$77 | $134 | -$2,633 | -$857 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $130 | $2,175 | $2,813 | $10,153 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $2,165 | $12,757 | $10,153 |
| Financing Cash Flow | $130 | $2,165 | $12,757 | $10,153 |
| Forex Effect | -$43 | -$2 | -$10 | $0 |
| Net Chg. in Cash | -$1,744 | -$1,933 | -$287 | -$3,800 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,958 | $3,891 | $4,178 | $7,978 |
| End Cash | $214 | $1,958 | $3,891 | $4,178 |
| Free Cash Flow | -$1,755 | -$4,243 | -$10,909 | -$3,147 |